UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000003608
Receipt No. R000004374
Official scientific title of the study Imaging study using positron emission tomography with AV-45 for dementia
Date of disclosure of the study information 2010/05/12
Last modified on 2017/11/16 (Ver. 13)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Imaging study using positron emission tomography with AV-45 for dementia
Title of the study (Brief title) Positron emission tomography for dementia
Region
Japan

Condition
Condition dementia
Classification by specialty
Neurology Geriatrics Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the distribution and deposits of beta-amyloid in brain using positron emission tomography and the correlation between the imaging data and cognitive function in Alzheimer's disease and mild cognitive impairment.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Amyloid deposits and distribution in brain measured by positron emission tomography among patients and age-matched normal controls.
Key secondary outcomes To investigate the correlation between the cognitive function, brain MRI, and FDG-PET and amyloid deposits.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 5
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 PET, MRI, Neuropsychological test
Interventions/Control_2 PET, MRI, Neuropsychological test
Interventions/Control_3 PET, MRI, Neuropsychological test
Interventions/Control_4 PET, MRI, Neuropsychological test
Interventions/Control_5 PET, MRI, NEuropsychological test
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Subjects who have the ability to provide informed consent and adhere to the protocol.
Normal controls:
- Without past or current history of cognitive dysfunction
- Mini-Mental State Exam score is 28 or more
Alzheimer's disease:
- Subject who meet the diagnostic criteria of Alzheimer's disease on International classification of Diseases 10th revision
- Informed consents are obtained from patients and one of their family members
Mild cognitive impairment:
- Memory complaints by subject that is verified by a study partner
- Objective cognitive impairment
- General cognition and functional performance sufficiently preserved
- Not meet the criteria of dementia
Mental disorder with cognitive impairment
Age-related macular degeneration
Key exclusion criteria Exclusion criteria:
- With past or current history of serious medical illness and/or brain organic diseases
- Subject who is contraindicated for the use of MRI
- With past or current history of severe liver disease, kidney disease, heart disease, allergy, or severe drug allergy
- Subjects who are judged as not suitable for participation in this study
Target sample size 75

Research contact person
Name of lead principal investigator Yoshiro Okubo, M.D., Ph.D.
Organization Nippon Medical School
Division name Department of Neuropsychiatry
Address 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
TEL 03-3822-2131
Email okubo-y@nms.ac.jp

Public contact
Name of contact person Amane Tateno, M.D., Ph.D.
Organization Nippon Medical School
Division name Department of Neuropsychiatry
Address 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
TEL 03-3822-2131
Homepage URL
Email amtateno@nms.ac.jp

Sponsor
Institute Nippon Medical School
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 日本医科大学付属病院健診医療センター、日本医科大学付属病院、メディカルサテライト八重洲クリニック神田分院

Other administrative information
Date of disclosure of the study information
2010 Year 05 Month 12 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2010 Year 04 Month 16 Day
Anticipated trial start date
2010 Year 05 Month 01 Day
Last follow-up date
2017 Year 04 Month 01 Day
Date of closure to data entry
2017 Year 07 Month 01 Day
Date trial data considered complete
2017 Year 10 Month 01 Day
Date analysis concluded
2017 Year 12 Month 31 Day

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information

Management information
Registered date
2010 Year 05 Month 12 Day
Last modified on
2017 Year 11 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004374